Opportunity timeline
In plain English
The NIH is seeking information from qualified businesses that can provide full-service medicinal chemistry support for therapeutic development. Work may include project management, compound logistics, synthesis, computational chemistry, SAR analysis, and in vitro ADMET studies across exploratory, hit-to-lead, and lead optimization stages, supporting 1–10 projects at once. Small businesses, including eligible socioeconomic categories, are encouraged to respond with their capabilities and size status under NAICS 541715. Responses are due by 1:00 p.m. Eastern on September 14, 2026, and must reference 75N98026R00144SB.
About this opportunity
This is a Small Business Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified business sources; (2) determine whether they are small businesses (e.g., 8(a), Veteran-owned small businesses, service-disabled Veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, and women-owned small businesses); (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition; and (4) the availability of domestically manufactured and commercial…
Time remaining
Closes Sep 14, 2026
Related Opportunities

Illumina DRAGEN Tier 3 Throughput License and v4 Server

Emergent Drug Panel-Version 2 (EDP-V2) Kit

Medicinal Chemistry Support Program for Therapeutic Development (MCSP)

Health Advisory Committees Research and Support

N66001-26-R-0030 - Academic Research MAC
Bid details are gathered and summarized automatically. Please verify details at the original source.
Ref No.
BS-5226FC

